The Danish multinational pharmaceutical company Novo Nordisk is one of the largest diabetes care providers in the world. Researchers from Novo Nordisk’s two main R&D sections, the Biopharm Research Unit and the Diabetes Research Unit, are regular visitors at the MAX IV Laboratory and measurements at the facility have provided important puzzle pieces in the development of the company’s products.

Read more about how the research facility within Science Link helps develop products for the benefit of mankind, Case Novo Nordisk

Print icon